Cargando…

Cognitive dysfunction in Nigerian women with epilepsy on carbamazepine and levetiracetam monotherapy

BACKGROUND: This study aims to identify the determinants of cognitive dysfunction and compare the effect of CPZ and LTC on cognition in WWE. METHODS: An observational study involving 87 consenting adult WWE aged between 16 and 40 years on LTC or CZP monotherapy. At enrollment, an interviewer‐based q...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogunjimi, Luqman, Yaria, Joseph, Makanjuola, Akintomiwa, Alabi, Akinyinka, Osalusi, Bamidele, Oboh, David, Olusola‐Bello, Mojisola, Aderinola, Adeyinka, Ogunniyi, Adesola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035450/
https://www.ncbi.nlm.nih.gov/pubmed/33666367
http://dx.doi.org/10.1002/brb3.2038
_version_ 1783676701392240640
author Ogunjimi, Luqman
Yaria, Joseph
Makanjuola, Akintomiwa
Alabi, Akinyinka
Osalusi, Bamidele
Oboh, David
Olusola‐Bello, Mojisola
Aderinola, Adeyinka
Ogunniyi, Adesola
author_facet Ogunjimi, Luqman
Yaria, Joseph
Makanjuola, Akintomiwa
Alabi, Akinyinka
Osalusi, Bamidele
Oboh, David
Olusola‐Bello, Mojisola
Aderinola, Adeyinka
Ogunniyi, Adesola
author_sort Ogunjimi, Luqman
collection PubMed
description BACKGROUND: This study aims to identify the determinants of cognitive dysfunction and compare the effect of CPZ and LTC on cognition in WWE. METHODS: An observational study involving 87 consenting adult WWE aged between 16 and 40 years on LTC or CZP monotherapy. At enrollment, an interviewer‐based questionnaire was used to obtain demographic and clinical information from participants. The diagnosis of epilepsy was mainly clinical and supported by electroencephalographic (EEG) features and classified based on recommendation by the 2017 International League Against Epilepsy (ILAE). Zung Self‐Reporting Depression Scale (ZSRDS) was used to assess the mood of participants. The Community Screening Interview for Dementia (CSID) was used to assess various cognition domains. The National Hospital Seizure Severity Scale (NHS‐3) was used to assess disease severity. RESULTS: There were statistical differences between the CZP and LTC groups in all domains of cognition assessed except for orientation. The total CSID scores of the LTC group were 59.2 (4.9) as opposed to CZP group, 57.2 (5.0); p: .005. Those with focal onset seizures had lower median total CSID score (58; IQR: 54–62) when compared to those with generalized onset seizures (62; IQR: 58–62), p: .012. There was a significant correlation between ZSRD score and NHS‐3 score; rho: 0.30, p: .007. Bivariate analysis shows statistically significant correlation between total CSID score and ZSRDS (rho: −0.65), BMI (rho: 0.22), and NHSS‐3 score (rho: −0.36), respectively. However, the effect of AED on CSID scores was lost after multivariate quantile regression with only ZSRDS retaining significance. CONCLUSION: Depression, seizure severity, type and structural etiology were associated with cognitive impairment among WWE. However, on regression model, only depression was statistically significant. The presence of more risks for cognitive impairment in the CZP group limits possible conclusion of LTC superiority.
format Online
Article
Text
id pubmed-8035450
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80354502021-04-14 Cognitive dysfunction in Nigerian women with epilepsy on carbamazepine and levetiracetam monotherapy Ogunjimi, Luqman Yaria, Joseph Makanjuola, Akintomiwa Alabi, Akinyinka Osalusi, Bamidele Oboh, David Olusola‐Bello, Mojisola Aderinola, Adeyinka Ogunniyi, Adesola Brain Behav Original Research BACKGROUND: This study aims to identify the determinants of cognitive dysfunction and compare the effect of CPZ and LTC on cognition in WWE. METHODS: An observational study involving 87 consenting adult WWE aged between 16 and 40 years on LTC or CZP monotherapy. At enrollment, an interviewer‐based questionnaire was used to obtain demographic and clinical information from participants. The diagnosis of epilepsy was mainly clinical and supported by electroencephalographic (EEG) features and classified based on recommendation by the 2017 International League Against Epilepsy (ILAE). Zung Self‐Reporting Depression Scale (ZSRDS) was used to assess the mood of participants. The Community Screening Interview for Dementia (CSID) was used to assess various cognition domains. The National Hospital Seizure Severity Scale (NHS‐3) was used to assess disease severity. RESULTS: There were statistical differences between the CZP and LTC groups in all domains of cognition assessed except for orientation. The total CSID scores of the LTC group were 59.2 (4.9) as opposed to CZP group, 57.2 (5.0); p: .005. Those with focal onset seizures had lower median total CSID score (58; IQR: 54–62) when compared to those with generalized onset seizures (62; IQR: 58–62), p: .012. There was a significant correlation between ZSRD score and NHS‐3 score; rho: 0.30, p: .007. Bivariate analysis shows statistically significant correlation between total CSID score and ZSRDS (rho: −0.65), BMI (rho: 0.22), and NHSS‐3 score (rho: −0.36), respectively. However, the effect of AED on CSID scores was lost after multivariate quantile regression with only ZSRDS retaining significance. CONCLUSION: Depression, seizure severity, type and structural etiology were associated with cognitive impairment among WWE. However, on regression model, only depression was statistically significant. The presence of more risks for cognitive impairment in the CZP group limits possible conclusion of LTC superiority. John Wiley and Sons Inc. 2021-03-05 /pmc/articles/PMC8035450/ /pubmed/33666367 http://dx.doi.org/10.1002/brb3.2038 Text en © 2021 The Authors. Brain and Behavior published by Wiley Periodicals LLC https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Ogunjimi, Luqman
Yaria, Joseph
Makanjuola, Akintomiwa
Alabi, Akinyinka
Osalusi, Bamidele
Oboh, David
Olusola‐Bello, Mojisola
Aderinola, Adeyinka
Ogunniyi, Adesola
Cognitive dysfunction in Nigerian women with epilepsy on carbamazepine and levetiracetam monotherapy
title Cognitive dysfunction in Nigerian women with epilepsy on carbamazepine and levetiracetam monotherapy
title_full Cognitive dysfunction in Nigerian women with epilepsy on carbamazepine and levetiracetam monotherapy
title_fullStr Cognitive dysfunction in Nigerian women with epilepsy on carbamazepine and levetiracetam monotherapy
title_full_unstemmed Cognitive dysfunction in Nigerian women with epilepsy on carbamazepine and levetiracetam monotherapy
title_short Cognitive dysfunction in Nigerian women with epilepsy on carbamazepine and levetiracetam monotherapy
title_sort cognitive dysfunction in nigerian women with epilepsy on carbamazepine and levetiracetam monotherapy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035450/
https://www.ncbi.nlm.nih.gov/pubmed/33666367
http://dx.doi.org/10.1002/brb3.2038
work_keys_str_mv AT ogunjimiluqman cognitivedysfunctioninnigerianwomenwithepilepsyoncarbamazepineandlevetiracetammonotherapy
AT yariajoseph cognitivedysfunctioninnigerianwomenwithepilepsyoncarbamazepineandlevetiracetammonotherapy
AT makanjuolaakintomiwa cognitivedysfunctioninnigerianwomenwithepilepsyoncarbamazepineandlevetiracetammonotherapy
AT alabiakinyinka cognitivedysfunctioninnigerianwomenwithepilepsyoncarbamazepineandlevetiracetammonotherapy
AT osalusibamidele cognitivedysfunctioninnigerianwomenwithepilepsyoncarbamazepineandlevetiracetammonotherapy
AT obohdavid cognitivedysfunctioninnigerianwomenwithepilepsyoncarbamazepineandlevetiracetammonotherapy
AT olusolabellomojisola cognitivedysfunctioninnigerianwomenwithepilepsyoncarbamazepineandlevetiracetammonotherapy
AT aderinolaadeyinka cognitivedysfunctioninnigerianwomenwithepilepsyoncarbamazepineandlevetiracetammonotherapy
AT ogunniyiadesola cognitivedysfunctioninnigerianwomenwithepilepsyoncarbamazepineandlevetiracetammonotherapy